Zollinger-Ellison syndrome is a condition in which the body produces too much of the hormone gastrin. Most of the time, a small tumor (gastrinoma) in the pancreas or small intestine is the source of the extra gastrin in the blood.
Z-E syndrome; Gastrinoma
Zollinger-Ellison syndrome is caused by tumors. These growths are most often found in the head of the pancreas and the upper small intestine. The tumors are called gastrinomas. High levels of gastrin cause production of too much stomach acid.
Gastrinomas occur as single tumors or several tumors. One half to two thirds of single gastrinomas are cancerous (malignant) tumors. These tumors often spread to the liver and nearby lymph nodes.
Many people with gastrinomas have several tumors as part of a condition called multiple endocrine neoplasia type I (MEN I). Tumors may develop in the pituitary gland (brain) and parathyroid gland (neck) as well as in the pancreas.
Symptoms may include:
Signs include ulcers in the stomach and small intestine.
Drugs called proton pump inhibitors (omeprazole, lansoprazole, and others) are used for treating this problem. These drugs reduce acid production by the stomach. This helps the ulcers in the stomach and small intestine heal. These medicines also relieve abdominal pain and diarrhea.
Surgery to remove a single gastrinoma may be done if the tumors have not spread to other organs. Surgery on the stomach (gastrectomy) to control acid production is rarely needed.
David Metz is a Gastroenterologist in Philadelphia, Pennsylvania. Metz has been practicing medicine for over 41 years and is rated as an Elite expert by MediFind in the treatment of Zollinger-Ellison Syndrome. He is also highly rated in 21 other conditions, according to our data. His top areas of expertise are Zollinger-Ellison Syndrome, Pancreatic Islet Cell Tumor, Gastroesophageal Reflux Disease, Endoscopy, and Colonoscopy. Metz is currently accepting new patients.
Douglas Fraker is a Surgical Oncologist and a General Surgeon in Philadelphia, Pennsylvania. Fraker has been practicing medicine for over 40 years and is rated as an Elite expert by MediFind in the treatment of Zollinger-Ellison Syndrome. He is also highly rated in 44 other conditions, according to our data. His top areas of expertise are Zollinger-Ellison Syndrome, Hyperparathyroidism, Neuroendocrine Tumor, Gastrectomy, and Tissue Biopsy. Fraker is currently accepting new patients.
Sara Massironi practices in Monza, Italy. Massironi is rated as an Elite expert by MediFind in the treatment of Zollinger-Ellison Syndrome. She is also highly rated in 16 other conditions, according to our data. Her top areas of expertise are Chronic Erosive Gastritis, Zollinger-Ellison Syndrome, Gastritis, Endoscopy, and Liver Transplant.
The cure rate is low, even when it is found early and the tumor is removed. However, gastrinomas grow slowly. People with this condition may live for many years after the tumor is found. Acid-suppressing medicines work well to control the symptoms.
Complications may include:
Contact your health care provider if you have severe abdominal pain that does not go away, especially if it occurs with diarrhea.
Summary: Neuroendocrine tumours (NETs) are generally slow growing, but some can be aggressive and resistant to treatment. Compared to healthy cells, the surface of these tumor cells has a greater number of special molecules called somatostatin receptors (SSTR). Somatostatin receptor scintigraphy and conventional imaging are used to detect NETs. This study proposes 68Gallium(68Ga)-DOTATOC positron emission ...
Summary: This randomized phase II trial studies how well giving temozolomide with or without capecitabine works in treating patients with advanced pancreatic neuroendocrine tumors. Drugs used in chemotherapy, such as temozolomide and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is ...
Published Date: November 02, 2022
Published By: Michael M. Phillips, MD, Emeritus Professor of Medicine, The George Washington University School of Medicine, Washington, DC. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Öberg K. Neuroendocrine tumors and related disorders. In: Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ, eds. Williams Textbook of Endocrinology. 14th ed. Philadelphia, PA: Elsevier; 2020:chap 45.
Strosberg JR, Al-Toubah T. Neuroendocrine tumors. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 34.